SU799646A3 - Способ получени 5-(4 -диметила-МиНОбЕНзОил)-2-иНдАНКАРбОНОВОй КиС-лОТы, EE СОлЕй или эфиРОВ - Google Patents

Способ получени 5-(4 -диметила-МиНОбЕНзОил)-2-иНдАНКАРбОНОВОй КиС-лОТы, EE СОлЕй или эфиРОВ Download PDF

Info

Publication number
SU799646A3
SU799646A3 SU792746906A SU2746906A SU799646A3 SU 799646 A3 SU799646 A3 SU 799646A3 SU 792746906 A SU792746906 A SU 792746906A SU 2746906 A SU2746906 A SU 2746906A SU 799646 A3 SU799646 A3 SU 799646A3
Authority
SU
USSR - Soviet Union
Prior art keywords
group
esters
formula
indane
salts
Prior art date
Application number
SU792746906A
Other languages
English (en)
Inventor
Бэйса Мишель
Сотель Франси
Депэн Жан-Клод
Бетбедэ-Матибэ Ани
Original Assignee
Лифа Лионнэз Эндюстриель Фарма-Сетик (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лифа Лионнэз Эндюстриель Фарма-Сетик (Фирма) filed Critical Лифа Лионнэз Эндюстриель Фарма-Сетик (Фирма)
Application granted granted Critical
Publication of SU799646A3 publication Critical patent/SU799646A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ 5-(4-ДИМЕТИЛАМИНОБЕНЗОЙД) -2-ИНДАНКАРБОНОВОЙ КИСЛОТЫ, ЕЕ СОЛЕЙ ИЛИ ЭФИРОБ
Пример 2. Смешивают 5,6 т (0,017 моль) 5-(V -диметиламинобензоил )-инданметилкарбоксилата и 1,95 г (0,0348 Моль) кали  в 60 мл метанола . Растворитель отгон ют, остаток перекристаллизовывают из этилацетата. Получают твердое вещество с температурой плавлени  164-165с (в капилл ре ) .
Элементный анализ:
Найдено,%: С 73,90, Н 6, 4,53.
Вычислено,%: С 73,77/ Н 6,19; N 4,53.

Claims (1)

1. Патент Японии 77-07.949, кл. С 07 С 61/38, опублик. 21.01 77.
SU792746906A 1976-12-14 1979-04-06 Способ получени 5-(4 -диметила-МиНОбЕНзОил)-2-иНдАНКАРбОНОВОй КиС-лОТы, EE СОлЕй или эфиРОВ SU799646A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7637574A FR2374032A2 (fr) 1976-12-14 1976-12-14 Nouveaux acides carboxyliques derives de l'indane

Publications (1)

Publication Number Publication Date
SU799646A3 true SU799646A3 (ru) 1981-01-23

Family

ID=9181028

Family Applications (1)

Application Number Title Priority Date Filing Date
SU792746906A SU799646A3 (ru) 1976-12-14 1979-04-06 Способ получени 5-(4 -диметила-МиНОбЕНзОил)-2-иНдАНКАРбОНОВОй КиС-лОТы, EE СОлЕй или эфиРОВ

Country Status (21)

Country Link
JP (1) JPS5373548A (ru)
AT (1) AT355559B (ru)
AU (1) AU515268B2 (ru)
BE (1) BE861826R (ru)
CA (1) CA1088554A (ru)
CH (1) CH627728A5 (ru)
DD (1) DD133323A6 (ru)
DE (1) DE2753315A1 (ru)
DK (1) DK144640C (ru)
ES (1) ES465056A2 (ru)
FR (1) FR2374032A2 (ru)
GB (1) GB1584298A (ru)
HU (1) HU177226B (ru)
IE (1) IE46013B1 (ru)
IL (2) IL60599A0 (ru)
MX (1) MX4954E (ru)
NL (1) NL7713876A (ru)
NO (1) NO774285L (ru)
SE (1) SE436740B (ru)
SU (1) SU799646A3 (ru)
ZA (1) ZA777438B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2526124T3 (es) * 2010-06-16 2015-01-07 Cymabay Therapeutics, Inc. Agonistas del receptor GPR120 y sus usos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4980053A (ru) * 1972-12-05 1974-08-02
JPS5838416B2 (ja) * 1974-05-31 1983-08-23 武田薬品工業株式会社 カンジヨウカゴウブツノセイゾウホウ
JPS5335944B2 (ru) * 1974-05-21 1978-09-29

Also Published As

Publication number Publication date
BE861826R (fr) 1978-06-14
IL60598A0 (en) 1980-09-16
SE436740B (sv) 1985-01-21
NO774285L (no) 1978-06-15
ATA892577A (de) 1979-08-15
DE2753315A1 (de) 1978-06-15
DK144640B (da) 1982-04-26
AU515268B2 (en) 1981-03-26
FR2374032A2 (fr) 1978-07-13
SE7714110L (sv) 1978-06-15
AU3153077A (en) 1979-06-21
CA1088554A (fr) 1980-10-28
DK144640C (da) 1982-10-04
DK554677A (da) 1978-06-15
HU177226B (en) 1981-08-28
IL60599A0 (en) 1980-09-16
AT355559B (de) 1980-03-10
CH627728A5 (en) 1982-01-29
DD133323A6 (de) 1978-12-27
ZA777438B (en) 1979-05-30
IE46013L (en) 1978-06-14
IE46013B1 (en) 1983-01-26
MX4954E (es) 1983-01-13
GB1584298A (en) 1981-02-11
NL7713876A (nl) 1978-06-16
FR2374032B2 (ru) 1979-03-30
JPS5373548A (en) 1978-06-30
ES465056A2 (es) 1979-01-16

Similar Documents

Publication Publication Date Title
SU578883A3 (ru) Способ получени пиразолоизохинолинов или их солей
SU689615A3 (ru) Способ получени оптически активного алкилхризантемата
GB1512420A (en) Cyclopropane-1-carboxylic acid derivatives for use as intermediates in the preparation of insecticides
SU799646A3 (ru) Способ получени 5-(4 -диметила-МиНОбЕНзОил)-2-иНдАНКАРбОНОВОй КиС-лОТы, EE СОлЕй или эфиРОВ
US3227724A (en) Process for preparing 2-methyl-3-hydroxypyridines
US3778450A (en) Certain bicyclic lactones
KR930003864B1 (ko) d-2-(6-메톡시-2-나프틸)-프로피온산의 제조방법
US2449191A (en) Phenacetylaminomethylcrotonic acid
US3910958A (en) Process for preparing arylacetic acids and esters thereof
IE43461L (en) Cyclopropane derivatives.
US4009172A (en) 2,3,3A,6,7,7A-Hexahydro-thieno[3,2-b]pyridin-(4H)5-ones
LUTZ et al. THE CIS AND TRANS 3-AROYL-2, 3-DIMETHYLACRYLIC1 ACIDS WITH PARTICULAR REFERENCE TO THE OPEN-CHAIN AND CYCLIC FORMS OF THE CIS DERIVATIVES
US5179208A (en) Process for preparing d-2-(6-methoxy-2-naphthyl)-propionic acid and intermediate thereof
ES421284A1 (es) Procedimiento para la preparacion de derivados de acidos pirrocolinaceticos.
KR860000848B1 (ko) 소염진통 작용을 갖는 아릴알칸산 유도체의 프탈리딜에스테르 제조방법
US3950355A (en) 5-chlorocarbonyl
SU656515A3 (ru) Способ получени производных фталазона
SU536160A1 (ru) Способ получени 1-арил-3,3-дифенилпропанонов-1
SU591456A1 (ru) Способ получени -нитроацетофенонов
SU369116A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СПИРО-р-ДИКЕТОЛАКТОНОВ ИНДАНДИОНОВОГО РЯДА
SU568648A1 (ru) Способ получени 3-фенил- 3-бутенолидов
US3907905A (en) 5-(1,2,3,4-Tetrahydro-6-methoxy-2-naphthyl)-2-hydroxy-1-methylcyclopentaneethanols
US4208526A (en) Process for the preparation of thiazolidin-4-one-acetic acid derivatives
SU458236A1 (ru) Способ получени моно- -алкоксизамещенных виниловых эфиров кислот п тивалентного фосфора
JPS5555135A (en) Preparation of d-2-(6-methoxy-2-naphthyl)-propionic acid